Clinical trial
TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment
NCT00023439 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00023439 |
|---|---|
| Title | TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment |
| Official title | Study of the Performance of Several Nucleic Acid Amplification Methodologies in the Diagnosis and Management of Active TB |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | US Department of Veterans Affairs U.S. Fed |
| Status | Completed |
| Study type | Observational |
| Conditions | Tuberculosis |
| Intervention type | Other |
| Interventions | Nucleic Acid Amplification Methods for diagnosis |
| Enrollment | 300 |
| Start date | May 1, 2000 |
| First posted | Sep 10, 2001 |
| Last update posted | Aug 3, 2011 |
| Countries | Canada, South Africa, Uganda, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: